May premium magazine: Early warnings and near misses

biosafety

A biosafety level 4 lab.

How to make biomedical research (and biosafety labs) less dangerous and more ethical, post-COVID-19

By Laura H. Kahn | Biosecurity

The Trump’s administration’s misaligned approach to national biodefense

By Reid Kirby | Biosecurity

Biosecurity: The opportunities and threats of industrialization and personalization

By Gigi Kwik Gronvall | Biosecurity

Winning the battle against emerging pathogens: A South African response

By Louise Bezuidenhout, Chandre Gould | Biosecurity